Chong Kun Dang will conduct joint marketing with Allergan Korea on eye disease treatments
Chong Kun Dang (CEO Jung-woo Kim)had an agreement ceremony at Grand Hyatt Seoul on the 13thfor joint marketing with Allergan Korea over two types of eye drops for ophthalmologic diseases.
Through the agreement, Chong Kun Dang will conduct co-marketing and sales of the Allergan’s xerophthalmia tr...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.